RTP company to work with Johns Hopkins and Tufts on diagnostic of 'silent killer'

Research Triangle Park metabolomics developer Metabolon has reached a deal with two health care titans to develop a new tool to help in diagnosing chronic kidney disease. Kidney disease can be caused by diabetes, a growing epidemic worldwide, and a diagnostic test to better identify early stages of kidney disease – when it is still treatable – could serve a valuable role. Metabolon reached the deal with Johns Hopkins University and Tufts Medical Center to develop a test that will require just…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news